| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 American Medical Laboratories, 4230 Burnham Ave., Las Vegas, NV 89119-5410.
aAuthor for correspondence. Fax 702-733-7589; e-mail Jess.Evans{at}aml.com.
Background: Methods for analysis of the single-nucleotide polymorphism (SNP) known as factor V Leiden (FVL) are described. The technique provides rapid, highly accurate detection of the point mutation that encodes for replacement of arginine-506 with glutamine. After formal assay qualification, 758 clinical samples that had previously been analyzed by the InvaderTM Monoplex Assay were tested as research samples in a commercial clinical laboratory.
Methods: Primers specific for factor V (FV) were prepared, and PCR was performed. Samples were analyzed using the NanoChip® Molecular Biology Workstation with fluorescently labeled reporters for wild-type and SNP sequences.
Results: Of the 635 samples classified by the Third WaveTM assay as FV wild type, 10 were identified as heterozygous FVL by the NanoChip technique. Similarly, of the 114 putative heterozygous samples, 4 were wild type, and of the 9 reported homozygous samples, 6 were homozygous, 2 were heterozygous, and 1 was FV wild type by the NanoChip assay. All 17 results that were discordant with the Third Wave analysis were confirmed by DNA sequencing to be correctly classified by the NanoChip technology. The Nanochip system was 100% accurate in characterizing wild-type, heterozygous, and homozygous samples compared with accuracies of 99.2%, 90.2%, and 100% for the comparable Third Wave analysis.
Conclusions: The NanoChip microelectronic chip array technology is an accurate and convenient method for FVL screening of research samples in a clinical laboratory environment.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  G. Amicarelli, D. Adlerstein, E. Shehi, F. Wang, and G. M. Makrigiorgos Genotype-Specific Signal Generation Based on Digestion of 3-Way DNA Junctions: Application to KRAS Variation Detection Clin. Chem., October 1, 2006; 52(10): 1855 - 1863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bortolin, M. Black, H. Modi, I. Boszko, D. Kobler, D. Fieldhouse, E. Lopes, J.-M. Lacroix, R. Grimwood, P. Wells, et al. Analytical Validation of the Tag-It High-Throughput Microsphere-Based Universal Array Genotyping Platform: Application to the Multiplex Detection of a Panel of Thrombophilia-Associated Single-Nucleotide Polymorphisms Clin. Chem., November 1, 2004; 50(11): 2028 - 2036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Frusconi, B. Giusti, L. Rossi, S. Bernabini, F. Poggi, I. Giotti, R. Abbate, G. Pepe, and F. Torricelli Improvement of Low-Density Microelectronic Array Technology to Characterize 14 Mutations/Single-Nucleotide Polymorphisms from Several Human Genes on a Large Scale Clin. Chem., April 1, 2004; 50(4): 775 - 777. [Full Text] [PDF]
|
|
|
|
|
|
C. French, C. Li, C. Strom, W. Sun, R. Van Atta, B. Gonzalez, and M. Wood Detection of the Factor V Leiden Mutation by a Modified Photo-Cross-Linking Oligonucleotide Hybridization Assay Clin. Chem., February 1, 2004; 50(2): 296 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-M. Simundic, E. Topic, and M. Stefanovic Detection of Factor V Leiden by PCR-SSCP using GMATM Precast Elchrom Scientific Gels Clinical and Applied Thrombosis/Hemostasis, July 1, 2003; 9(3): 227 - 231. [Abstract] [PDF]
|
|
|
|
|
|
M. Erali, B. Schmidt, E. Lyon, and C. Wittwer Evaluation of Electronic Microarrays for Genotyping Factor V, Factor II, and MTHFR Clin. Chem., May 1, 2003; 49(5): 732 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. F. Cooper and R. V. Goering Development of a Universal Probe for Electronic Microarray and Its Application in Characterization of the Staphylococcus aureus polC Gene J. Mol. Diagn., February 1, 2003; 5(1): 28 - 33. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
